Bioverativ Inc (BIVV) files its latest 10-K with SEC for the fiscal year ended on December 31, 2017. Bioverativ Inc is a global biotechnology company which focuses on the discovery, research, ...
On January 22, 2018, Sanofi (NYSE: SNY, $44.81, market capitalization: $113.2 billion) and Bioverativ (NASDAQ: BIVV, $103.10, market capitalization: $11.2 billion) announced a definite agreement under ...
Bioverativ (BIVV) is a biotechnology company focused on the discovery and commercialization of innovative therapies for the treatment of hemophilia and other rare blood disorders. The company was spun ...
At close: 28 June at 6:07:38 pm GMT-4 ...
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Bioverativ Inc (Symbol: BIVV), where a total volume of 6,878 contracts has been ...
At close: 28 June at 6:07:38 pm GMT-4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results